Tandem Diabetes Care Announces First Quarter 2019 Financial Results and Updated 2019 Financial Guidance

Go back to Tandem Diabetes Care Announces First Quarter 2019 Financial Results and Updated 2019 Financial Guidance

Tandem Diabetes (TNDM) Q1 Revenues Show Beat Beat; Guides Higher

April 30, 2019 4:46 PM EDT

Tandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.40), $0.10 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $66 million versus the consensus estimate of $47.51 million.

Our explosive growth in the first quarter was driven by strong domestic demand... More